id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0664-0136,FDA,FDA-2009-N-0664,Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2010-01-11T05:00:00Z,2010,1,,,2010-01-20T04:11:31Z,2010-00173,0,0,0900006480a7b2e4
FDA-2009-N-0664-0135,FDA,FDA-2009-N-0664,The General Hospital and Personal Use Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2010-01-11T05:00:00Z,2010,1,,,2010-01-20T04:11:31Z,2010-00174,0,0,0900006480a7b2a5
FDA-2009-N-0664-0134,FDA,FDA-2009-N-0664,Anesthetic and Life Support Drugs Advisory Committee; Cancellation,Notice,N-Notice,2010-01-06T05:00:00Z,2010,1,,,2010-01-06T12:57:43Z,E9-31306,0,0,0900006480a7791a
FDA-2009-N-0664-0133,FDA,FDA-2009-N-0664,Public Workshop: Medical Device Quality System Regulation Educational Forum on Risk Management Through the Product Life Cycle,Notice,NM-Notice of Meeting,2010-01-05T05:00:00Z,2010,1,,,2010-01-05T14:05:54Z,E9-31198,0,0,0900006480a76f8b
FDA-2009-N-0664-0131,FDA,FDA-2009-N-0664,Medical Device Interoperability; Public Workshop,Notice,NM-Notice of Meeting,2009-12-30T05:00:00Z,2009,12,2009-12-30T05:00:00Z,,2009-12-30T17:44:57Z,E9-30871,0,0,0900006480a740cd
FDA-2009-N-0664-0130,FDA,FDA-2009-N-0664,Advisory Committees; Tentative Schedule of Meetings for 2010,Notice,N-Notice,2009-12-30T05:00:00Z,2009,12,2009-12-30T05:00:00Z,,2009-12-30T17:39:27Z,E9-30973,0,0,0900006480a74087
FDA-2009-N-0664-0132,FDA,FDA-2009-N-0664,Second Annual Sentinel Initiative Public Workshop,Notice,NM-Notice of Meeting,2009-12-30T05:00:00Z,2009,12,2009-12-30T05:00:00Z,,2009-12-30T17:49:10Z,E9-30971,0,0,0900006480a740d2
FDA-2009-N-0664-0129,FDA,FDA-2009-N-0664,Gastrointestinal Drugs Advisory Committee Notice of Meeting,Notice,NM-Notice of Meeting,2009-12-23T05:00:00Z,2009,12,2009-12-23T05:00:00Z,,2009-12-23T19:25:45Z,E9-30442,0,0,0900006480a704a2
FDA-2009-N-0664-0127,FDA,FDA-2009-N-0664,Oncologic Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,,2009-12-17T19:59:52Z,E9-29989,0,0,0900006480a6ca01
FDA-2009-N-0664-0128,FDA,FDA-2009-N-0664,"Food and Drug Administration Clinical Trial Requirements, Regulations, Compliance and Good Clinical Practices; Public Workshop",Notice,NM-Notice of Meeting,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,,2009-12-17T20:10:36Z,E9-30017,0,0,0900006480a6ca05
FDA-2009-N-0664-0126,FDA,FDA-2009-N-0664,Meetings: Anesthetic and Life Support Drugs Advisory Committee,Notice,NM-Notice of Meeting,2009-12-08T05:00:00Z,2009,12,2009-12-08T05:00:00Z,,2009-12-08T15:43:55Z,E9-29211,0,0,0900006480a66771
FDA-2009-N-0664-0125,FDA,FDA-2009-N-0664,Meetings: Oncologic Drugs Advisory Committee,Notice,N-Notice,2009-12-08T05:00:00Z,2009,12,2009-12-08T05:00:00Z,,2009-12-08T15:45:20Z,E9-29208,0,0,0900006480a66745
FDA-2009-N-0664-0124,FDA,FDA-2009-N-0664,Meetings: Pediatric Advisory Committee; Correction,Notice,NCR-Notice of Correction,2009-11-30T05:00:00Z,2009,11,2009-11-30T05:00:00Z,,2009-11-30T15:10:02Z,E9-28448,0,0,0900006480a6026c
FDA-2009-N-0664-0123,FDA,FDA-2009-N-0664,Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-11-27T05:00:00Z,2009,11,2009-11-27T05:00:00Z,,2009-11-27T15:43:51Z,E9-28302,0,0,0900006480a5f50d
FDA-2009-N-0664-0121,FDA,FDA-2009-N-0664,Vaccines and Related Biological Products Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-11-19T05:00:00Z,2009,11,2009-11-19T05:00:00Z,,2009-11-19T15:00:23Z,E9-27728,0,0,0900006480a5aac9
FDA-2009-N-0664-0122,FDA,FDA-2009-N-0664,Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-11-19T05:00:00Z,2009,11,2009-11-19T05:00:00Z,,2009-11-19T15:04:24Z,E9-27741,0,0,0900006480a5ab09
FDA-2009-N-0664-0120,FDA,FDA-2009-N-0664,Anti-Infective Drugs Advisory Committee; Amendment of Notice,Notice,N-Notice,2009-11-18T05:00:00Z,2009,11,2009-11-18T05:00:00Z,,2009-11-18T17:43:36Z,E9-27693,0,0,0900006480a59038
FDA-2009-N-0664-0118,FDA,FDA-2009-N-0664,Oncologic Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-11-17T05:00:00Z,2009,11,,,2009-11-17T17:38:38Z,E9-27493,0,0,0900006480a593d0
FDA-2009-N-0664-0119,FDA,FDA-2009-N-0664,General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-11-17T05:00:00Z,2009,11,,,2009-11-17T17:42:04Z,E9-27491,0,0,0900006480a5942c
FDA-2009-N-0664-0117,FDA,FDA-2009-N-0664,Oncologic Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-11-17T05:00:00Z,2009,11,,,2009-11-17T17:35:10Z,E9-27490,0,0,0900006480a593f6
FDA-2009-N-0664-0115,FDA,FDA-2009-N-0664,Thermal Aspects of Radio Frequency Exposure; Public Workshop,Notice,NM-Notice of Meeting,2009-11-17T05:00:00Z,2009,11,,,2009-11-17T17:19:46Z,E9-27513,0,0,0900006480a59359
FDA-2009-N-0664-0116,FDA,FDA-2009-N-0664,National Mammography Quality Assurance Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-11-17T05:00:00Z,2009,11,,,2009-11-17T17:23:57Z,E9-27492,0,0,0900006480a5937c
FDA-2009-N-0664-0113,FDA,FDA-2009-N-0664,Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-11-02T05:00:00Z,2009,11,2009-11-02T05:00:00Z,,2009-11-02T18:26:56Z,E9-26259,0,0,0900006480a4f423
FDA-2009-N-0664-0112,FDA,FDA-2009-N-0664,"Ear, Nose, and Throat Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting",Notice,NM-Notice of Meeting,2009-11-02T05:00:00Z,2009,11,2009-11-02T05:00:00Z,,2009-11-02T18:17:54Z,E9-26260,0,0,0900006480a4f384
FDA-2009-N-0664-0114,FDA,FDA-2009-N-0664,Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Postponement of Meeting,Notice,N-Notice,2009-11-02T05:00:00Z,2009,11,2009-11-02T05:00:00Z,,2009-11-02T18:37:02Z,E9-26261,0,0,0900006480a4f471
FDA-2009-N-0664-0111,FDA,FDA-2009-N-0664,Pediatric Advisory Committee; Amendment of Notice,Notice,N-Notice,2009-11-02T05:00:00Z,2009,11,2009-11-02T05:00:00Z,,2009-11-02T18:00:14Z,E9-26262,0,0,0900006480a4f37c
FDA-2009-N-0664-0110,FDA,FDA-2009-N-0664,Science Advisory Board to the National Center for Toxicological Research Notice of Meeting,Notice,NM-Notice of Meeting,2009-10-28T04:00:00Z,2009,10,2009-10-28T04:00:00Z,,2009-10-28T16:52:12Z,E9-25941,0,0,0900006480a4cbb8
FDA-2009-N-0664-0108,FDA,FDA-2009-N-0664,"Emerging Arboviruses: Risk Assessment for Blood, Cell, Tissue, and Organ Safety; Public Workshop",Notice,NM-Notice of Meeting,2009-10-27T04:00:00Z,2009,10,,,2009-10-27T15:34:38Z,E9-25802,0,0,0900006480a4c09d
FDA-2009-N-0664-0107,FDA,FDA-2009-N-0664,Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-10-27T04:00:00Z,2009,10,,,2009-10-27T15:07:16Z,E9-25805,0,0,0900006480a4bff1
FDA-2009-N-0664-0106,FDA,FDA-2009-N-0664,Meetings: Anti-Infective Drugs Advisory Committee,Notice,NM-Notice of Meeting,2009-10-26T04:00:00Z,2009,10,,,2009-10-26T16:13:48Z,E9-25628,0,0,0900006480a4b831
FDA-2009-N-0664-0105,FDA,FDA-2009-N-0664,Meetings: Anti-Infective Drugs Advisory Committee,Notice,NM-Notice of Meeting,2009-10-26T04:00:00Z,2009,10,,,2009-10-26T15:48:03Z,E9-25627,0,0,0900006480a4b79e
FDA-2009-N-0664-0103,FDA,FDA-2009-N-0664,Request for Notification From Industry Organizations Interested in Participating in Selection Process for Nonvoting Industry Representatives on Public Advisory Committees and Request for Nominations for Nonvoting Industry Representatives on Public Advisory Committees,Notice,N-Notice,2009-10-22T04:00:00Z,2009,10,,,2009-10-22T14:05:58Z,E9-25407,0,0,0900006480a470b2
FDA-2009-N-0664-0104,FDA,FDA-2009-N-0664,Radiological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-10-22T04:00:00Z,2009,10,,,2009-10-22T14:04:33Z,E9-25406,0,0,0900006480a470d2
FDA-2009-N-0664-0100,FDA,FDA-2009-N-0664,Request for Nominations for Voting Members on Public Advisory Panels or Committees,Notice,N-Notice,2009-10-16T04:00:00Z,2009,10,2009-10-16T04:00:00Z,,2009-10-16T15:37:44Z,E9-24896,0,0,0900006480a433c9
FDA-2009-N-0664-0099,FDA,FDA-2009-N-0664,National Mammography Quality Assurance Advisory Committee; Notice of Postponement of Meeting,Notice,N-Notice,2009-10-16T04:00:00Z,2009,10,2009-10-16T04:00:00Z,,2009-10-16T15:24:35Z,E9-24895,0,0,0900006480a433b3
FDA-2009-N-0664-0102,FDA,FDA-2009-N-0664,The Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-10-16T04:00:00Z,2009,10,2009-10-16T04:00:00Z,,2009-10-16T16:03:58Z,E9-24893,0,0,0900006480a434bf
FDA-2009-N-0664-0101,FDA,FDA-2009-N-0664,Vaccines and Related Biological Products Advisory Committee; Notice of Meeting,Notice,,2009-10-16T04:00:00Z,2009,10,2009-10-16T04:00:00Z,,2009-10-16T15:44:37Z,E9-24894,0,0,0900006480a433cc
FDA-2009-N-0664-0098,FDA,FDA-2009-N-0664,Advancing Clinical Development of Molecular and Other Diagnostic Tests for Respiratory Tract Infections; Notice of Public Workshop,Notice,NM-Notice of Meeting,2009-10-15T04:00:00Z,2009,10,2009-10-15T04:00:00Z,,2009-10-15T15:53:15Z,E9-24828,0,0,0900006480a4227c
FDA-2009-N-0664-0094,FDA,FDA-2009-N-0664,Meetings: Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee,Notice,NM-Notice of Meeting,2009-10-06T04:00:00Z,2009,10,,,2009-10-06T15:12:33Z,E9-24016,0,0,0900006480a3bfb4
FDA-2009-N-0664-0096,FDA,FDA-2009-N-0664,Meetings: Pediatric Advisory Committee,Notice,NM-Notice of Meeting,2009-10-06T04:00:00Z,2009,10,,,2009-10-06T15:24:35Z,E9-24013,0,0,0900006480a3c015
FDA-2009-N-0664-0095,FDA,FDA-2009-N-0664,Meetings: Cardiovascular and Renal Drugs Advisory Committee,Notice,NM-Notice of Meeting,2009-10-06T04:00:00Z,2009,10,,,2009-10-06T15:17:28Z,E9-24015,0,0,0900006480a3bfb5
FDA-2009-N-0664-0097,FDA,FDA-2009-N-0664,Meetings: Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee,Notice,NM-Notice of Meeting,2009-10-06T04:00:00Z,2009,10,,,2009-10-06T15:30:26Z,E9-24014,0,0,0900006480a3c020
FDA-2009-N-0664-0093,FDA,FDA-2009-N-0664,Meetings: Oncologic Drugs Advisory Committee; Cancellation,Notice,N-Notice,2009-10-02T04:00:00Z,2009,10,2009-10-02T04:00:00Z,,2009-10-02T16:29:30Z,E9-23764,0,0,0900006480a38afd
FDA-2009-N-0664-0092,FDA,FDA-2009-N-0664,Meetings: National Mammography Quality Assurance Advisory Committee,Notice,NM-Notice of Meeting,2009-10-01T04:00:00Z,2009,10,2009-10-01T04:00:00Z,,2009-10-01T18:45:41Z,E9-23621,0,0,0900006480a34e51
FDA-2009-N-0664-0091,FDA,FDA-2009-N-0664,Meetings: Blood Products Advisory Committee,Notice,NM-Notice of Meeting,2009-09-29T04:00:00Z,2009,9,,,2009-09-29T16:42:52Z,E9-23434,0,0,0900006480a30b64
FDA-2009-N-0664-0089,FDA,FDA-2009-N-0664,Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-09-28T04:00:00Z,2009,9,2009-09-28T04:00:00Z,,2009-09-28T16:46:19Z,E9-23292,0,0,0900006480a2ea91
FDA-2009-N-0664-0090,FDA,FDA-2009-N-0664,Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-09-28T04:00:00Z,2009,9,2009-09-28T04:00:00Z,,2009-09-28T16:49:56Z,E9-23270,0,0,0900006480a2eb0c
FDA-2009-N-0664-0088,FDA,FDA-2009-N-0664,Anti-Infective Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-09-25T04:00:00Z,2009,9,2009-09-25T17:04:06Z,,2009-09-25T17:05:02Z,E9-23143,0,0,0900006480a2c202
FDA-2009-N-0664-0087,FDA,FDA-2009-N-0664,Risk Communication Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-09-24T04:00:00Z,2009,9,,,2009-09-24T16:22:43Z,E9-23001,0,0,0900006480a2ad13
FDA-2009-N-0664-0085,FDA,FDA-2009-N-0664,Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-09-22T04:00:00Z,2009,9,,,2009-09-22T15:48:24Z,E9-22819,0,0,0900006480a288d9
FDA-2009-N-0664-0086,FDA,FDA-2009-N-0664,Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-09-22T04:00:00Z,2009,9,,,2009-09-22T15:05:59Z,E9-22820,0,0,0900006480a288df
FDA-2009-N-0664-0084,FDA,FDA-2009-N-0664,Hematology and Pathology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-09-10T04:00:00Z,2009,9,2009-09-10T04:00:00Z,,2009-09-10T15:51:27Z,E9-21810,0,0,0900006480a20230
FDA-2009-N-0664-0083,FDA,FDA-2009-N-0664,"Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting",Notice,NM-Notice of Meeting,2009-09-09T04:00:00Z,2009,9,2009-09-09T04:00:00Z,,2009-09-09T16:08:47Z,E9-21557,0,0,0900006480a1f25c
FDA-2009-N-0664-0082,FDA,FDA-2009-N-0664,Oncologic Drugs Advisory Committee; Amendment of Notice,Notice,N-Notice,2009-09-09T04:00:00Z,2009,9,2009-09-09T04:00:00Z,,2009-09-09T16:04:54Z,E9-21556,0,0,0900006480a1f226
FDA-2009-N-0664-0080,FDA,FDA-2009-N-0664,2009 Parenteral Drug Association and Food and Drug Administration Joint Regulatory Conference,Notice,NM-Notice of Meeting,2009-09-08T04:00:00Z,2009,9,,,2009-09-08T16:47:56Z,E9-21546,0,0,0900006480a1e413
FDA-2009-N-0664-0081,FDA,FDA-2009-N-0664,"Co-Sponsorship Agreement between U.S. Food and Drug Administration [Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH), Office of Regulatory Affairs (ORA)] and Parenteral Drug Association",Supporting & Related Material,BKG-Background Material,2009-09-08T04:00:00Z,2009,9,,,2009-09-08T16:37:26Z,,0,0,0900006480a1eaf1
FDA-2009-N-0664-0079,FDA,FDA-2009-N-0664,Blood Establishment Computer Software: Understanding What to Include in a 510(k) Submission; Public Workshop,Notice,NM-Notice of Meeting,2009-08-28T04:00:00Z,2009,8,2009-08-28T04:00:00Z,,2009-08-28T17:22:45Z,E9-20781,0,0,0900006480a16a84
FDA-2009-N-0664-0078,FDA,FDA-2009-N-0664,Industry Exchange Workshop on Food and Drug Administration Drug and Device Requirements; Public Workshop,Notice,NM-Notice of Meeting,2009-08-26T04:00:00Z,2009,8,2009-08-26T04:00:00Z,,2009-08-26T16:16:56Z,E9-20340,0,0,0900006480a12e06
FDA-2009-N-0664-0075,FDA,FDA-2009-N-0664,Oncologic Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-08-25T04:00:00Z,2009,8,,,2009-08-25T16:33:13Z,E9-20379,0,0,0900006480a11acc
FDA-2009-N-0664-0074,FDA,FDA-2009-N-0664,Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-08-25T04:00:00Z,2009,8,,,2009-08-25T16:27:13Z,E9-20380,0,0,0900006480a11acb
FDA-2009-N-0664-0077,FDA,FDA-2009-N-0664,Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-08-25T04:00:00Z,2009,8,,,2009-08-25T17:14:34Z,E9-20376,0,0,0900006480a11bd8
FDA-2009-N-0664-0073,FDA,FDA-2009-N-0664,Oncologic Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-08-25T04:00:00Z,2009,8,,,2009-08-25T16:28:19Z,E9-20378,0,0,0900006480a11a9e
FDA-2009-N-0664-0076,FDA,FDA-2009-N-0664,Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Amendment of Notice,Notice,NCR-Notice of Correction,2009-08-25T04:00:00Z,2009,8,,,2009-08-25T16:53:08Z,E9-20377,0,0,0900006480a11bac
FDA-2009-N-0664-0072,FDA,FDA-2009-N-0664,Methodologies for Post-Approval Studies of Medical Devices; Public Workshop,Notice,NM-Notice of Meeting,2009-08-19T04:00:00Z,2009,8,,,2009-08-25T17:19:05Z,09-19904,0,0,0900006480a0d32c
FDA-2009-N-0664-0071,FDA,FDA-2009-N-0664,Public Workshop: Development of Antiviral Products for Treatment of Smallpox and Related Poxvirus Infections,Notice,NM-Notice of Meeting,2009-08-18T04:00:00Z,2009,8,,,2009-08-18T17:18:40Z,E9-19781,0,0,0900006480a0c1d0
FDA-2009-N-0664-0070,FDA,FDA-2009-N-0664,Meetings: Vaccines and Related Biological Products Advisory Committee,Notice,NM-Notice of Meeting,2009-08-17T04:00:00Z,2009,8,,,2009-08-17T16:28:55Z,E9-19639,0,0,0900006480a0b4d3
FDA-2009-N-0664-0067,FDA,FDA-2009-N-0664,Meetings: Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee,Notice,NM-Notice of Meeting,2009-08-11T04:00:00Z,2009,8,,,2009-08-11T18:02:17Z,E9-19105,0,0,0900006480a057ca
FDA-2009-N-0664-0068,FDA,FDA-2009-N-0664,Meetings: Joint Meeting of Oncologic Drugs Advisory Committee,Notice,NM-Notice of Meeting,2009-08-11T04:00:00Z,2009,8,,,2009-08-11T18:01:41Z,,0,0,0900006480a059a0
FDA-2009-N-0664-0069,FDA,FDA-2009-N-0664,Meetings: Oncologic Drugs Advisory Committee,Notice,NM-Notice of Meeting,2009-08-11T04:00:00Z,2009,8,,,2009-08-11T18:00:48Z,E9-19106,0,0,0900006480a0589b
FDA-2009-N-0664-0066,FDA,FDA-2009-N-0664,Antiviral Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-07-31T04:00:00Z,2009,7,2009-07-31T04:00:00Z,,2009-07-31T17:43:56Z,E9-18355,0,0,09000064809fef93
FDA-2009-N-0664-0065,FDA,FDA-2009-N-0664,Arthritis Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-07-31T04:00:00Z,2009,7,2009-07-31T04:00:00Z,,2009-07-31T17:30:44Z,E9-18356,0,0,09000064809fef5c
FDA-2009-N-0664-0064,FDA,FDA-2009-N-0664,Science Board to the Food and Drug Administration; Notice of Meeting,Notice,NM-Notice of Meeting,2009-07-28T04:00:00Z,2009,7,2009-07-28T04:00:00Z,,2009-07-28T17:39:34Z,E9-17961,0,0,09000064809fc1fa
FDA-2009-N-0664-0063,FDA,FDA-2009-N-0664,Risk Communication Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-07-21T04:00:00Z,2009,7,2009-07-21T04:00:00Z,,2009-07-21T16:36:58Z,E9-17222,0,0,09000064809f7217
FDA-2009-N-0664-0062,FDA,FDA-2009-N-0664,Meetings: Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee,Notice,NM-Notice of Meeting,2009-07-13T04:00:00Z,2009,7,2009-07-13T04:00:00Z,,2009-07-13T20:48:19Z,E9-16409,0,0,09000064809f014e
FDA-2009-N-0664-0061,FDA,FDA-2009-N-0664,Vaccines and Related Biological Products Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-07-08T04:00:00Z,2009,7,2009-07-08T04:00:00Z,,2009-07-08T16:14:37Z,E9-16099,0,0,09000064809ec1fb
FDA-2009-N-0664-0060,FDA,FDA-2009-N-0664,Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting,Notice,NM-Notice of Meeting,2009-07-08T04:00:00Z,2009,7,2009-07-08T04:00:00Z,,2009-07-08T16:10:11Z,E9-16136,0,0,09000064809ec19f
FDA-2009-N-0664-0059,FDA,FDA-2009-N-0664,Blood Products Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-07-08T04:00:00Z,2009,7,2009-07-08T04:00:00Z,,2009-07-08T16:11:06Z,E9-16101,0,0,09000064809ec198
FDA-2009-N-0664-0058,FDA,FDA-2009-N-0664,Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-07-02T04:00:00Z,2009,7,2009-07-02T04:00:00Z,,2009-07-02T16:36:44Z,E9-15680,0,0,09000064809e892b
FDA-2009-N-0664-0057,FDA,FDA-2009-N-0664,The Essentials of Medical Device Regulations: A Primer for Manufacturers and Importers; Public Seminar,Notice,NM-Notice of Meeting,2009-06-24T04:00:00Z,2009,6,2009-06-24T04:00:00Z,,2009-06-24T16:25:03Z,E9-14907,0,0,09000064809d773d
FDA-2009-N-0664-0056,FDA,FDA-2009-N-0664,Advisory Committee for Reproductive Health Drugs; Notice of Meeting,Notice,NM-Notice of Meeting,2009-06-23T04:00:00Z,2009,6,2009-06-23T04:00:00Z,,2009-06-23T14:34:44Z,E9-14638,0,0,09000064809d64eb
FDA-2009-N-0664-0055,FDA,FDA-2009-N-0664,Meetings: Peripheral and Central Nervous System Drugs Advisory Committee,Notice,NM-Notice of Meeting,2009-06-11T04:00:00Z,2009,6,2009-06-11T04:00:00Z,,2009-06-11T18:58:44Z,E9-13767,0,0,09000064809cc2ac
FDA-2009-N-0664-0050,FDA,FDA-2009-N-0664,Issues in the Design of Clinical Trials of Antimycobacterial Drugs for Treatment of Tuberculosis; Public Workshop,Notice,NM-Notice of Meeting,2009-06-09T04:00:00Z,2009,6,2009-06-09T04:00:00Z,,2009-06-10T11:28:07Z,E9-13419,0,0,09000064809c9dd4
FDA-2009-N-0664-0054,FDA,FDA-2009-N-0664,Oncologic Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-06-09T04:00:00Z,2009,6,2009-06-09T04:00:00Z,,2009-06-10T12:04:39Z,E9-13372,0,0,09000064809c9e36
FDA-2009-N-0664-0053,FDA,FDA-2009-N-0664,Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-06-09T04:00:00Z,2009,6,2009-06-09T04:00:00Z,,2009-06-10T11:59:40Z,E9-13375,0,0,09000064809c9e32
FDA-2009-N-0664-0052,FDA,FDA-2009-N-0664,Hematology and Pathology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-06-09T04:00:00Z,2009,6,2009-06-09T04:00:00Z,,2009-06-10T11:56:10Z,E9-13373,0,0,09000064809c9e10
FDA-2009-N-0664-0051,FDA,FDA-2009-N-0664,Psychopharmacologic Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-06-09T04:00:00Z,2009,6,2009-06-09T04:00:00Z,,2009-06-10T11:31:00Z,E9-13371,0,0,09000064809c9dd6
FDA-2009-N-0664-0049,FDA,FDA-2009-N-0664,Meetings: Cardiovascular and Renal Drugs Advisory Committee,Notice,NM-Notice of Meeting,2009-06-08T04:00:00Z,2009,6,2009-06-08T04:00:00Z,,2009-06-08T19:22:40Z,E9-13315,0,0,09000064809c8b28
FDA-2009-N-0664-0048,FDA,FDA-2009-N-0664,Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-06-01T04:00:00Z,2009,6,2009-06-01T04:00:00Z,,2009-06-01T15:27:24Z,E9-12625,0,0,09000064809c0ce1
FDA-2009-N-0664-0047,FDA,FDA-2009-N-0664,Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting,Notice,NM-Notice of Meeting,2009-06-01T04:00:00Z,2009,6,2009-06-01T04:00:00Z,,2009-06-01T14:53:32Z,E9-12627,0,0,09000064809c0c5d
FDA-2009-N-0664-0046,FDA,FDA-2009-N-0664,Food and Drug Administration Clinical Trial Requirements; Public Workshop,Notice,NM-Notice of Meeting,2009-05-22T04:00:00Z,2009,5,2009-05-22T04:00:00Z,,2009-05-22T16:24:33Z,E9-12051,0,0,09000064809ac09d
FDA-2009-N-0664-0045,FDA,FDA-2009-N-0664,Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-05-20T04:00:00Z,2009,5,2009-05-20T04:00:00Z,,2009-05-20T18:33:12Z,E9-11734,0,0,09000064809a364b
FDA-2009-N-0664-0044,FDA,FDA-2009-N-0664,Gastrointestinal Drugs Advisory Committee; Cancellation,Notice,N-Notice,2009-05-19T04:00:00Z,2009,5,2009-05-19T04:00:00Z,,2009-05-19T17:18:17Z,E9-11725,0,0,090000648099fc2d
FDA-2009-N-0664-0043,FDA,FDA-2009-N-0664,Pediatric Advisory Committee; Notice of Meeting - Notice of Meeting,Notice,NM-Notice of Meeting,2009-05-15T04:00:00Z,2009,5,2009-05-15T15:09:16Z,,2009-05-15T15:09:51Z,E9-11317,0,0,0900006480994531
FDA-2009-N-0664-0042,FDA,FDA-2009-N-0664,Arthritis Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-05-08T04:00:00Z,2009,5,2009-05-08T04:00:00Z,,2009-05-08T20:24:45Z,E9-10729,0,0,090000648097f987
FDA-2009-N-0664-0040,FDA,FDA-2009-N-0664,Meetings: Transmissible Spongiform Encephalopathies Advisory Committee,Notice,NM-Notice of Meeting,2009-05-06T04:00:00Z,2009,5,2009-05-06T04:00:00Z,,2009-05-06T19:24:19Z,E9-10454,0,0,09000064809792f6
FDA-2009-N-0664-0041,FDA,FDA-2009-N-0664,Meetings: Implementation of Post-Approval Studies for Medical Devices; Public Workshop,Notice,NM-Notice of Meeting,2009-05-06T04:00:00Z,2009,5,2009-05-06T04:00:00Z,,2009-05-06T19:22:56Z,E9-10426,0,0,090000648097937c
FDA-2009-N-0664-0039,FDA,FDA-2009-N-0664,Oncologic Drugs Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-05-05T04:00:00Z,2009,5,2009-05-05T04:00:00Z,,2009-05-05T15:41:35Z,E9-10349,0,0,0900006480975ee2
FDA-2009-N-0664-0038,FDA,FDA-2009-N-0664,Science Board to the Food and Drug Administration; Notice of Meeting,Notice,NM-Notice of Meeting,2009-04-28T04:00:00Z,2009,4,2009-04-28T04:00:00Z,,2009-04-28T15:52:22Z,E9-09643,0,0,090000648096e3c5
FDA-2009-N-0664-0035,FDA,FDA-2009-N-0664,"Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting",Notice,NM-Notice of Meeting,2009-04-28T04:00:00Z,2009,4,2009-04-28T04:00:00Z,,2009-04-28T15:52:19Z,E9-09592,0,0,090000648096e34b
FDA-2009-N-0664-0037,FDA,FDA-2009-N-0664,Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,NM-Notice of Meeting,2009-04-28T04:00:00Z,2009,4,2009-04-28T04:00:00Z,,2009-04-28T15:52:20Z,E9-09642,0,0,090000648096e36f